Menu
GWAS Study

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Childs EJ, Mocci E, Campa D et al.

26098869 PubMed ID
GWAS Study Type
21494 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CE
Childs EJ
ME
Mocci E
CD
Campa D
BP
Bracci PM
GS
Gallinger S
GM
Goggins M
LD
Li D
NR
Neale RE
OS
Olson SH
SG
Scelo G
AL
Amundadottir LT
BW
Bamlet WR
BM
Bijlsma MF
BA
Blackford A
BM
Borges M
BP
Brennan P
BH
Brenner H
BH
Bueno-de-Mesquita HB
CF
Canzian F
CG
Capurso G
CG
Cavestro GM
CK
Chaffee KG
CS
Chanock SJ
CS
Cleary SP
CM
Cotterchio M
FL
Foretova L
FC
Fuchs C
FN
Funel N
GM
Gazouli M
HM
Hassan M
HJ
Herman JM
HI
Holcatova I
HE
Holly EA
HR
Hoover RN
HR
Hung RJ
JV
Janout V
KT
Key TJ
KJ
Kupcinskas J
KR
Kurtz RC
LS
Landi S
LL
Lu L
ME
Malecka-Panas E
MA
Mambrini A
MB
Mohelnikova-Duchonova B
NJ
Neoptolemos JP
OA
Oberg AL
OI
Orlow I
PC
Pasquali C
PR
Pezzilli R
RC
Rizzato C
SA
Saldia A
SA
Scarpa A
SR
Stolzenberg-Solomon RZ
SO
Strobel O
TF
Tavano F
VY
Vashist YK
VP
Vodicka P
WB
Wolpin BM
YH
Yu H
PG
Petersen GM
RH
Risch HA
KA
Klein AP
Chapter II

Abstract

Summary of the research findings

Pancreatic cancer is the fourth leading cause of cancer death in the developed world. Both inherited high-penetrance mutations in BRCA2 (ref. 2), ATM, PALB2 (ref. 4), BRCA1 (ref. 5), STK11 (ref. 6), CDKN2A and mismatch-repair genes and low-penetrance loci are associated with increased risk. To identify new risk loci, we performed a genome-wide association study on 9,925 pancreatic cancer cases and 11,569 controls, including 4,164 newly genotyped cases and 3,792 controls in 9 studies from North America, Central Europe and Australia. We identified three newly associated regions: 17q25.1 (LINC00673, rs11655237, odds ratio (OR) = 1.26, 95% confidence interval (CI) = 1.19-1.34, P = 1.42 × 10(-14)), 7p13 (SUGCT, rs17688601, OR = 0.88, 95% CI = 0.84-0.92, P = 1.41 × 10(-8)) and 3q29 (TP63, rs9854771, OR = 0.89, 95% CI = 0.85-0.93, P = 2.35 × 10(-8)). We detected significant association at 2p13.3 (ETAA1, rs1486134, OR = 1.14, 95% CI = 1.09-1.19, P = 3.36 × 10(-9)), a region with previous suggestive evidence in Han Chinese. We replicated previously reported associations at 9q34.2 (ABO), 13q22.1 (KLF5), 5p15.33 (TERT and CLPTM1), 13q12.2 (PDX1), 1q32.1 (NR5A2), 7q32.3 (LINC-PINT), 16q23.1 (BCAR1) and 22q12.1 (ZNRF3). Our study identifies new loci associated with pancreatic cancer risk.

7,638 cases, 7,364 controls

Chapter III

Study Statistics

Key metrics and study information

21494
Total Participants
GWAS
Study Type
Yes
Replicated
2,287 cases, 4,205 controls
Replication Participants
NR, European, European, NR, Hispanic or Latin American, African unspecified, Asian unspecified
Ancestry
Poland, Czech Republic, Italy, Greece, Germany, Lithuania, U.S., Australia, Canada
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.